Progesterone 100 MG capsule 100S
Ended Awarded Last action
- Contract number
- SPE2DR26FJC0Q
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,473
Award facts
- Contract value 100% obligated
- $15,472.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,472.98 to AmerisourceBergen Drug Corp for the supply of Progesterone 100 mg capsules (100-count units). The contract, awarded on December 3, 2025, with an ultimate completion date of December 4, 2025, represents a firm fixed-price delivery order with no set-aside designation. This order is being fulfilled from AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a comprehensive $999.999 billion pharmaceutical support vehicle running through December 2026 that enables the distributor to supply pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement through its DLA prime contract. The company's extensive portfolio of federal awards demonstrates its capability to deliver a broad spectrum of pharmaceuticals including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for progesterone aligns with the company's established role as a primary supplier of hormone treatments and other pharmaceutical commodities within the federal medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FJC0Q?
SPE2DR26FJC0Q was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 3, 2025.
How much is contract SPE2DR26FJC0Q worth?
The government has obligated $15,473 on SPE2DR26FJC0Q.
Is contract SPE2DR26FJC0Q an order under another contract?
Yes. SPE2DR26FJC0Q is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJC0Q competed?
The extent of competition for SPE2DR26FJC0Q was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award